Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | -0.07% | +8.11% | -79.49% |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
Financials (USD)
Sales 2022 | 10.88 | Sales 2023 | 19.59 | Capitalization | 4.9M |
---|---|---|---|---|---|
Net income 2022 | -25M | Net income 2023 | -14M | EV / Sales 2022 | 568,219 x |
Net cash position 2022 | 3.04M | Net cash position 2023 | 385K | EV / Sales 2023 | 230,324 x |
P/E ratio 2022 |
-0.19
x | P/E ratio 2023 |
-0.29
x | Employees | 19 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.56% |
Latest transcript on Agile Therapeutics, Inc.
1 day | -0.07% | ||
1 week | +8.11% | ||
Current month | +17.65% | ||
1 month | -33.58% | ||
3 months | -73.68% | ||
6 months | -78.14% | ||
Current year | -79.49% |
Managers | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 04-01-31 |
Scott Coiante
DFI | Director of Finance/CFO | 57 | 10-11-30 |
Paul Korner
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-08-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 04-01-31 |
Seth Fischer
BRD | Director/Board Member | 68 | 16-07-27 |
John Hubbard
BRD | Director/Board Member | 67 | 14-11-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.4 | -0.07% | 85,721 |
24-04-24 | 0.4003 | +8.19% | 73,534 |
24-04-23 | 0.37 | -6.09% | 94,553 |
24-04-22 | 0.394 | +3.68% | 15,937 |
24-04-19 | 0.38 | +2.70% | 47,561 |
Delayed Quote OTC Markets, April 25, 2024 at 02:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.49% | 2.74M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- AGRX Stock